The importance of ASCT2 in breast cancers is demonstrated also by the activation of ubiquitin ligase RNF5, ascribed to chemotherapy-induced ER stress, that leads to degradation of glutamine transporters including ASCT2 (Jeon et al., 2015; Moses and Neckers, 2015). The gene discussed is SLC1A5; the disease is breast cancer.